Showing results (1721-1730 of 2,364) with videos related to

Sort By:
Pageof 237
JACC. Cardiovascular Interventions|April 23, 2021
Effect of Mitral Valve Gradient After MitraClip on Outcomes in Secondary Mitral Regurgitation: Results From the COAPT TrialRim Halaby, Howard C Herrmann, Zachary M Gertz, et al.
The American Journal of Cardiology|March 19, 2013
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 yearsJohn K Forrest, Alexandra J Lansky, Stephanie M Meller, et al.
Circulation. Heart Failure|November 12, 2020
Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT TrialIoanna Kosmidou, JoAnn Lindenfeld, William T Abraham, et al.
Nature Communications|June 8, 2021
Nutrients cause consolidation of soil carbon flux to small proportion of bacterial communityBram W Stone, Junhui Li, Benjamin J Koch, et al.
Circulation. Cardiovascular Interventions|March 16, 2019
Periprocedural Outcomes According to Timing of Clopidogrel Loading Dose in Patients Who Did Not Receive P2Y12 Inhibitor PretreatmentJeremie Abtan, Gregory Ducrocq, Philippe Gabriel Steg, et al.
The International Journal of Cardiovascular Imaging|June 14, 2024
Intravascular imaging-guided percutaneous coronary intervention for heavily calcified coronary lesions: a systematic review and meta-analysisDoosup Shin, David Hong, Mandeep Singh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trialTobias Geisler, Michal Droppa, Meinrad Gawaz, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
American Heart Journal|June 5, 2017
Relationship between therapeutic effects on infarct size in acute myocardial infarction and therapeutic effects on 1-year outcomes: A patient-level analysis of randomized clinical trialsHarry P Selker, James E Udelson, Robin Ruthazer, et al.
Circulation|August 27, 2003
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trialJames E Tcheng, David E Kandzari, Cindy L Grines, et al.
Pageof 237